Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
143.97
+7.35 (5.38%)
At close: Sep 11, 2026, 4:00 PM EDT
144.65
+0.68 (0.47%)
After-hours: Sep 11, 2026, 7:59 PM EDT

Moderna Stock Forecast

Stock Price Forecast

According to 23 analysts polled by S&P Global, Moderna stock has a consensus rating of "Hold" and an average price target of $116.5. The average 1-year stock price forecast is 19.08% lower than the current stock price, while the lowest is $45 (-68.74%) and the highest is $170 (+18.08%).

Price Target: $116.5 (-19.08%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$45$116.5$125$170
Change-68.74%-19.08%-13.18%+18.08%

Analyst Ratings

The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy222244
Buy221211
Hold161617161717
Sell233211
Strong Sell111100
Total232424232323

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Evercore ISI
Evercore ISI
Hold
Maintains
$80
HoldMaintains$80-44.43%Sep 11, 2026
Berenberg Bank
Berenberg Bank
Hold
Maintains
$45$100
HoldMaintains$45$100-30.54%Sep 11, 2026
DBS
DBS
Hold
Maintains
$150
HoldMaintains$150+4.19%Sep 11, 2026
Rothschild & Co Redburn
Rothschild & Co Redburn
Sell
Downgrades
$40$81
SellDowngrades$40$81-43.74%Sep 3, 2026
Argus Research
Argus Research
Buy
Upgrades
$180
BuyUpgrades$180+25.03%Aug 28, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.10B
from 1.94B
Increased by 8.07%
Revenue Next Year
2.44B
from 2.10B
Increased by 16.04%
EPS This Year
-8.40
from -7.26
EPS Next Year
-4.47
from -8.40
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
18.47B19.26B6.85B3.24B1.94B2.10B
Revenue Growth
2,200.25%4.29%-64.45%-52.75%-39.93%8.07%
Operating Income
13.30B9.42B-4.24B-3.95B-3.07B-3.49B
Net Income
12.20B8.36B-4.71B-3.56B-2.82B-3.31B
EPS
-----7.26-8.40
Free Cash Flow
9.29B3.67B-2.36B-3.09B-1.33B-2.86B
No. Analysts
-----20
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.2B
Avg2.1B
Low2.0B

Revenue Growth

Revenue Growth202620272028
High
10.8%
Avg
8.1%
Low
1.0%

EPS Forecast

EPS202620272028
High-6.66
Avg-8.40
Low-10.55

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-